Tech Bio: Why data-driven technologies are the way forward

In this Campden FB interview, Hanadi Jabado, Managing Partner at Sana Capital, explains why TechBio is now the most powerful lever for transforming healthcare — combining biological insight with data, AI, and computational tools to make drug discovery faster, safer, and radically more cost-efficient.

She discusses the future of data-driven health, the critical need for global data sharing (and why data donation could soon be more impactful than blood or organ donation), and how TechBio will shift healthcare from treatment to prediction and prevention.

Hanadi also outlines the gap in Europe: cutting-edge research and data — but not enough early-stage capital — and why Sana Capital was built to unlock this opportunity.

Click below to read the full interview on Campden FB's website:

Tech Bio: Why data-driven technologies are the way forward